SI3037104T1 - Izolacija in prečiščevanje protiteles anti-IL-13 z uporabo afinitetne kromatografije beljakovine A - Google Patents

Izolacija in prečiščevanje protiteles anti-IL-13 z uporabo afinitetne kromatografije beljakovine A

Info

Publication number
SI3037104T1
SI3037104T1 SI201032028T SI201032028T SI3037104T1 SI 3037104 T1 SI3037104 T1 SI 3037104T1 SI 201032028 T SI201032028 T SI 201032028T SI 201032028 T SI201032028 T SI 201032028T SI 3037104 T1 SI3037104 T1 SI 3037104T1
Authority
SI
Slovenia
Prior art keywords
antibodies
isolation
purification
protein
affinity chromatography
Prior art date
Application number
SI201032028T
Other languages
English (en)
Inventor
Robert Hickman
Original Assignee
Abbvie Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc. filed Critical Abbvie Inc.
Publication of SI3037104T1 publication Critical patent/SI3037104T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A61K39/39525—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI201032028T 2009-10-20 2010-10-20 Izolacija in prečiščevanje protiteles anti-IL-13 z uporabo afinitetne kromatografije beljakovine A SI3037104T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25341109P 2009-10-20 2009-10-20
EP15189425.0A EP3037104B1 (en) 2009-10-20 2010-10-20 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography

Publications (1)

Publication Number Publication Date
SI3037104T1 true SI3037104T1 (sl) 2020-10-30

Family

ID=43900936

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201032028T SI3037104T1 (sl) 2009-10-20 2010-10-20 Izolacija in prečiščevanje protiteles anti-IL-13 z uporabo afinitetne kromatografije beljakovine A

Country Status (27)

Country Link
US (5) US8491904B2 (sl)
EP (2) EP2491055A2 (sl)
JP (1) JP5914342B2 (sl)
KR (2) KR20170136649A (sl)
CN (2) CN104744560A (sl)
AU (1) AU2010310748C1 (sl)
BR (1) BR112012009289B8 (sl)
CA (1) CA2775595A1 (sl)
CY (1) CY1123952T1 (sl)
DK (1) DK3037104T3 (sl)
ES (1) ES2813398T3 (sl)
HR (1) HRP20201118T1 (sl)
HU (1) HUE053489T2 (sl)
IL (1) IL218897A (sl)
IN (1) IN2012DN02778A (sl)
LT (1) LT3037104T (sl)
MX (2) MX2012004711A (sl)
NZ (2) NZ599100A (sl)
PL (1) PL3037104T3 (sl)
PT (1) PT3037104T (sl)
RS (1) RS60577B1 (sl)
RU (1) RU2603055C2 (sl)
SG (1) SG10201406713XA (sl)
SI (1) SI3037104T1 (sl)
TW (1) TWI515202B (sl)
WO (1) WO2011050071A2 (sl)
ZA (1) ZA201202720B (sl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101710472B1 (ko) * 2007-11-30 2017-02-27 글락소 그룹 리미티드 항원-결합 작제물
SG10201702922VA (en) * 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
DK3037104T3 (da) 2009-10-20 2020-07-20 Abbvie Inc Isolering og renselse af anti-il-13 antistoffer ved brug af protein a beslægtet kromatografi
US9029517B2 (en) 2010-07-30 2015-05-12 Emd Millipore Corporation Chromatography media and method
AR085911A1 (es) 2011-03-16 2013-11-06 Sanofi Sa Dosis terapeutica segura de una proteina similar a un anticuerpo con region v dual
EP2820149A1 (en) * 2012-02-27 2015-01-07 Biogen Idec MA Inc. High-throughput method for sialic acid quantitation
WO2014145208A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Hydrophobic interaction protein chromatography under no-salt conditions
CA2910065C (en) * 2013-05-15 2023-09-19 Medimmune Limited Purification of recombinantly produced polypeptides
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
SG11201508835YA (en) 2013-07-12 2015-11-27 Merck Patent Gmbh Removal of fragments from a sample containing a target protein using activated carbon
CA2921999C (en) * 2013-09-13 2023-03-21 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
EP4163633A1 (en) * 2013-09-13 2023-04-12 F. Hoffmann-La Roche AG Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
JPWO2015041218A1 (ja) * 2013-09-17 2017-03-02 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎＭｅｔｈｏｄａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎｍｅｔｈｏｄｕｓｉｎｇＣａｔｉｏｎＥｘｃｈａｎｇｅｒａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）
CN105017418B (zh) * 2014-03-27 2021-02-23 上海药明康德新药开发有限公司 单克隆抗体纯化工艺方法
FR3025515B1 (fr) * 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
KR102162753B1 (ko) * 2014-12-08 2020-10-07 이엠디 밀리포어 코포레이션 혼합층 이온 교환 흡착제
WO2017027861A1 (en) 2015-08-13 2017-02-16 Amgen Inc. Charged depth filtration of antigen-binding proteins
TW201718623A (zh) * 2015-08-20 2017-06-01 建南德克公司 ＦkpＡ之純化及其用於製備重組多肽之用途
EP4276108A3 (en) 2016-04-27 2024-01-24 AbbVie Inc. Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies
IL264631B2 (en) 2016-08-16 2024-05-01 Regeneron Pharma A method for quantifying individual antibodies from a mixture
AU2017350807B2 (en) 2016-10-25 2022-07-07 Regeneron Pharmaceuticals, Inc. Methods and systems for chromatography data analysis
EP3551046B1 (en) 2016-12-07 2023-07-19 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
KR102140693B1 (ko) * 2017-04-14 2020-08-05 에이치케이이노엔 주식회사 양이온 교환 크로마토그래피를 이용한 유사항체 정제 방법
WO2019036626A1 (en) * 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. PROCESS FOR PURIFYING GLYCOSYLATED PROTEIN FROM GALECTINES AND OTHER HOST CELL CONTAMINANTS
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
JPWO2020022363A1 (ja) * 2018-07-25 2021-08-02 第一三共株式会社 抗体−薬物コンジュゲートの効果的な製造方法
CN110818789B (zh) * 2018-08-07 2023-02-28 三生国健药业（上海）股份有限公司 一种高纯度食蟹猴白细胞介素17a的纯化方法
EP3883634A1 (en) 2018-11-19 2021-09-29 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
TW202043253A (zh) * 2019-01-28 2020-12-01 美商安進公司 藉由將藥物物質和藥物產品過程整體化的生物製劑製造之連續製造過程
WO2020247574A1 (en) * 2019-06-05 2020-12-10 Seattle Genetics, Inc. Methods of purifying masked antibodies
MX2022001166A (es) * 2019-08-01 2022-02-23 Regeneron Pharma Metodo para inactivacion viral.
PE20221790A1 (es) 2019-12-06 2022-11-25 Regeneron Pharma Composiciones de proteina anti-vegf y metodos para producir la misma
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置
AU2021208632A1 (en) * 2020-01-17 2022-08-04 Regeneron Pharmaceuticals, Inc. Hydrophobic interaction chromatography for viral clearance
CN112326966A (zh) * 2020-11-02 2021-02-05 杭州昱鼎生物科技有限公司 一种新型冠状病毒抗原的快速检测试剂盒及其制备方法和应用

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (sl)
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4534972A (en) 1983-03-29 1985-08-13 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
DE3572982D1 (en) 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US5476996A (en) 1988-06-14 1995-12-19 Lidak Pharmaceuticals Human immune system in non-human animal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
ATE135370T1 (de) 1988-12-22 1996-03-15 Kirin Amgen Inc Chemisch modifizierte granulocytenkolonie erregender faktor
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
DE4041205A1 (de) 1990-12-21 1992-06-25 Schloemann Siemag Ag Verfahren und anlage zum auswalzen von warmbreitband aus stranggegossenen duennbrammen
ATE363532T1 (de) 1991-03-01 2007-06-15 Dyax Corp Verfahren zur herstellung bindender miniproteine
DE69233367T2 (de) 1991-04-10 2005-05-25 The Scripps Research Institute, La Jolla Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
WO1997002023A1 (en) * 1995-06-30 1997-01-23 Smithkline Beecham Corporation USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US6914128B1 (en) 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
DK1391511T3 (da) 2001-05-11 2008-09-29 Kirin Pharma Kk Humant kunstigt kromosom indeholdende human antistof lambda-let-kæde-gen
US7646782B1 (en) 2001-07-30 2010-01-12 Primrose Donald R Data link/physical layer packet buffering and flushing
CA2499269A1 (en) * 2002-09-17 2004-04-01 Gtc Biotherapeutics, Inc. Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1601697B1 (en) * 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
CN102276717B (zh) * 2003-10-27 2015-09-09 惠氏公司 使用羟磷灰石层析除去高分子量聚集体
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
AR049390A1 (es) * 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
TWI307630B (en) * 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins
SI1942939T2 (sl) 2005-09-30 2021-11-30 Medimmune Limited Sestavek protitelesa proti interlevkinu-13
GB0600488D0 (en) 2006-01-11 2006-02-22 Glaxo Group Ltd Immunoglobulins
BRPI0709726A2 (pt) * 2006-04-05 2011-07-26 Abbott Biotechnology Ltd. purificaÇço de anticorpo
WO2007123961A2 (en) * 2006-04-20 2007-11-01 Wyeth Purification processes for isolating purified vesicular stomatitis virus from cell culture
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
TW201522372A (zh) * 2006-09-08 2015-06-16 艾伯維巴哈馬有限公司 介白素-１３結合蛋白質
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
CN102395597A (zh) * 2009-03-11 2012-03-28 惠氏有限责任公司 纯化小模块免疫药物蛋白的方法
DK3037104T3 (da) 2009-10-20 2020-07-20 Abbvie Inc Isolering og renselse af anti-il-13 antistoffer ved brug af protein a beslægtet kromatografi

Also Published As

Publication number Publication date
US20160130339A1 (en) 2016-05-12
NZ599100A (en) 2014-07-25
PT3037104T (pt) 2020-07-07
AU2010310748B2 (en) 2015-05-21
US20110206687A1 (en) 2011-08-25
SG10201406713XA (en) 2014-11-27
EP3037104B1 (en) 2020-05-27
US9266950B2 (en) 2016-02-23
CN102711828A (zh) 2012-10-03
ZA201202720B (en) 2012-12-27
KR20120101002A (ko) 2012-09-12
CY1123952T1 (el) 2022-03-24
KR20170136649A (ko) 2017-12-11
RS60577B1 (sr) 2020-08-31
ES2813398T3 (es) 2021-03-23
HUE053489T2 (hu) 2021-06-28
MX2012004711A (es) 2012-05-23
BR112012009289B8 (pt) 2021-05-25
KR101830596B1 (ko) 2018-02-22
US11390668B2 (en) 2022-07-19
AU2010310748A1 (en) 2012-04-19
JP5914342B2 (ja) 2016-05-11
CN102711828B (zh) 2015-06-17
MX341136B (es) 2016-08-09
US9975948B2 (en) 2018-05-22
IN2012DN02778A (sl) 2015-09-18
EP2491055A2 (en) 2012-08-29
TW201125876A (en) 2011-08-01
CN104744560A (zh) 2015-07-01
TWI515202B (zh) 2016-01-01
US20220340656A1 (en) 2022-10-27
AU2010310748C1 (en) 2015-11-26
HRP20201118T1 (hr) 2020-10-30
BR112012009289B1 (pt) 2021-01-05
US8491904B2 (en) 2013-07-23
BR112012009289A2 (pt) 2017-04-04
DK3037104T3 (da) 2020-07-20
RU2603055C2 (ru) 2016-11-20
IL218897A0 (en) 2012-06-28
WO2011050071A3 (en) 2011-09-15
PL3037104T3 (pl) 2020-11-16
US20180230210A1 (en) 2018-08-16
JP2013508387A (ja) 2013-03-07
US20130287771A1 (en) 2013-10-31
EP3037104A1 (en) 2016-06-29
CA2775595A1 (en) 2011-04-28
BR112012009289A8 (pt) 2017-12-05
RU2012120751A (ru) 2013-11-27
LT3037104T (lt) 2020-09-10
WO2011050071A2 (en) 2011-04-28
NZ627668A (en) 2016-03-31
IL218897A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
ZA201202720B (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
IL244157A0 (en) Isolation and purification of antibodies using protein a affinity chromatography
EP2265129A4 (en) CHROMATOGRAPHERING OF ANTIBODIES
EP2513142A4 (en) MEMBRANES AND APPROPRIATE PROCEDURES FOR CLEANING ANTIBODIES
ZA201006150B (en) Purified immunoglobulin fusion proteins and methods of their purification
HK1205470A1 (en) High affinity human antibodies to human angiopoietin-2 -2
SG2013061528A (en) Methods for purifying antibodies using protein a affinity chromatography
EP2490780A4 (en) USE OF MIXED MODE CHROMATOGRAPHY FOR CAPTURE AND PURIFICATION OF BASIC ANTIBODY PRODUCTS
PL2190984T3 (pl) Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG
HRP20170234T1 (hr) Molekule antitijela koje imaju specifično vezanje za ljudski il-13
HK1185356A1 (zh) 用於通過親和色譜法的抗體和 - 融合蛋白純化的配體
PL2408794T3 (pl) Izolacja i oczyszczanie składników serwatki
IL216261A0 (en) IL-13 binding protein
EP2499192A4 (en) MEMBRANES FOR CHROMATOGRAPHY OF HYDROPHOBIC INTERACTION AND THEIR METHODS OF USE
EP2488544A4 (en) AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION
EP2519537A4 (en) CLEANING PROTEINS
EP2383336A4 (en) PEPTIDE CAPABLE OF BINDING TO AN IMMUNOGLOBULIN
EP2452196A4 (en) PURIFICATION OF MONOCLONAL ANTIBODIES
GB0709037D0 (en) Isolation of proteins
EP2540742A4 (en) MONOCLONAL ANTIBODIES OF ANTI-CYR61 PROTEIN AND USES THEREOF
IL218496A0 (en) Structural analysis of proteins
AU2009905049A0 (en) Affinity Ligands and Methods for Protein Purification